- ICH GCP
- Register voor klinische proeven in de VS.
- Klinische proef NCT01375153
Brain Natriuretic Peptide Effects on Appetite Regulating Hormones and Endothelial Derived Peptides (BNP/Appetite)
Effects of Brain Natriuretic Peptide on Appetite-regulating Hormones and Endothelial-derived Peptides
Studie Overzicht
Toestand
Conditie
Interventie / Behandeling
Gedetailleerde beschrijving
This is a prospective, single blinded randomized, placebo-controlled, cross-over study, which will be conducted in ten healthy volunteers.
Each subject will participate in two study days/sessions, separated by a washout period of at least two weeks. The sessions will last approximately 4.5 hours. The subjects will come after having fasted overnight. Two intravenous cannulas will be placed in the right and left antecubital vein for infusions and blood sampling, respectively.
The subjects will receive intravenously once placebo and once 3.0 pmol/kg/min human active BNP (BNP-32) as a continuous intravenous infusion given during 4 hours (between time points 0 and 240 minutes). The order of study drugs will be randomized.
During the whole study session (lasting about 4.5 hours) the subject will remain fasted and confined to bed rest.
The changes in subjective ratings of hunger and satiety over time will be evaluated by 100 mm visual analog scales (VAS) half-hourly (between time points 0 and 240 minutes). Herewith the subjects rate their feeling of hunger (Hunger-VAS forms include the question: How hungry do you feel? Subjects are required to mark their feeling of hunger in a scale from 0 to 100 mm) and satiety (Satiety-VAS forms include the question: How satt do you feel? Subjects are required to mark their feeling of hunger in a scale from 0 to 100 mm).
Blood samples will be withdrawn twice at baseline (time points -5 minutes and 0 minutes) and hourly afterwards. Samples will be immediately cooled on ice, centrifuged at 3000 rpm for 10 minutes and then stored at -20°C for the later measurement of ghrelin, peptide YY, adiponectin, corticotropin, cortisol, adrenaline, noradrenaline, insulin, adrenomedullin, endothelin, copeptin, growth differentiation factor 15, BNP and atrial natriuretic peptide. All assays will be performed using commercial radioimmunoassays and enzyme-linked immunosorbent assays at the very end of the study with samples belonging to (both study days) one subject being measured within one kit.
The changes in VAS and hormone concentrations over time will be evaluated using repeated measurements analysis of variance (ANOVA) using the SPSS release 12.0.1 statistical software.
Studietype
Inschrijving (Werkelijk)
Fase
- Niet toepasbaar
Contacten en locaties
Studie Locaties
-
-
-
Vienna, Oostenrijk, 1090
- Medical University of Vienna
-
Vienna, Oostenrijk, A-1090
- AKH, Medical University of Vienna
-
-
Deelname Criteria
Geschiktheidscriteria
Leeftijden die in aanmerking komen voor studie
Accepteert gezonde vrijwilligers
Geslachten die in aanmerking komen voor studie
Beschrijving
Inclusion Criteria:
- Men aged 18 to 40 years
- written informed consent
- BMI < 25 kg/m2
- no concomitant diseases
- BNP level within the normal range
- Normal renal function (serum creatinine of less then 1.2 mg/dL and/or creatinin clearance greater than 80ml/min)
Exclusion Criteria:
- systolic blood pressure < 90 mmHg
- impaired glucose tolerance or diabetes mellitus
- hyperthyroidism, hypothyroidism
- hepatic, renal or cardiovascular diseases
- malignancies
- history of medical therapy within 3 weeks prior to enrolment into the study
- history of anaphylaxis
Studie plan
Hoe is de studie opgezet?
Ontwerpdetails
- Primair doel: Ander
- Toewijzing: Gerandomiseerd
- Interventioneel model: Crossover-opdracht
- Masker: Enkel
Wapens en interventies
Deelnemersgroep / Arm |
Interventie / Behandeling |
---|---|
Placebo-vergelijker: Placebo
0,9% NaCl administered as a continuous intravenous infusion during four hours.
|
0.9% NaCl administered as a continuous intravenous infusion during four hours
Andere namen:
|
Actieve vergelijker: BNP
3.0 pmol/kg/min human active BNP administered as a continuous intravenous infusion during four hours.
|
3.0 pmol/kg/min human active BNP administered as a continuous intravenous infusion during four hours
|
Wat meet het onderzoek?
Primaire uitkomstmaten
Uitkomstmaat |
Maatregel Beschrijving |
Tijdsspanne |
---|---|---|
Changes in hunger scores on the visual analog scales (VAS) over time as compared to baseline (measured in mm)
Tijdsspanne: Time points -5, 0, 30, 60, 90, 120, 150, 180, 210 and 240 minutes
|
Subjects will be asked to rate their feeling of hunger in 100 mm VAS half-hourly (between time points 0 and 240 minutes). Hunger-VAS forms include the question: How hungry do you feel? Subjects are required to mark their feeling of hunger in a scale of 0 to 100 mm. |
Time points -5, 0, 30, 60, 90, 120, 150, 180, 210 and 240 minutes
|
Changes in satiety scores on the VAS over time as compared to baseline (measured in mm)
Tijdsspanne: Time points -5, 0, 30, 60, 90, 120, 150, 180, 210 and 240 minutes
|
Subjects will be asked to rate their feeling of satiety in 100 mm VAS half-hourly (between time points 0 and 240 minutes). Satiety-VAS forms include the question: How satt do you feel? Subjects are required to mark their feeling of satiety in a scale of 0 to 100 mm. |
Time points -5, 0, 30, 60, 90, 120, 150, 180, 210 and 240 minutes
|
Changes in plasma concentrations of ghrelin and acylated ghrelin over time as compared to baseline
Tijdsspanne: Timepoints -5, 0, 60, 120, 180 and 240 minutes.
|
Blood samples will be withdrawn from an intravenous cannula placed circa 10 minutes before the start of the study in the left antecubital vein.
Samples will be immediately cooled on ice, centrifuged at 3000 rpm for 10 minutes and then stored at -20°C for the later measurement of ghrelin and acylated ghrelin.
All assays will be performed using commercial assay kits at the very end of the study with samples belonging to (both study days) one subject being measured within one kit.
|
Timepoints -5, 0, 60, 120, 180 and 240 minutes.
|
Changes in plasma concentrations of peptide YY (PYY) over time as compared to baseline
Tijdsspanne: Timepoints -5, 0, 60, 120, 180 and 240 minutes.
|
Blood samples will be withdrawn from an intravenous cannula placed circa 10 minutes before the start of the study in the left antecubital vein.
Samples will be immediately cooled on ice, centrifuged at 3000 rpm for 10 minutes and then stored at -20°C for the later measurement of PYY.
All PYY assays will be performed using commercial radioimmunoassay kits at the very end of the study with samples belonging to (both study days) one subject being measured within one kit.
|
Timepoints -5, 0, 60, 120, 180 and 240 minutes.
|
Secundaire uitkomstmaten
Uitkomstmaat |
Maatregel Beschrijving |
Tijdsspanne |
---|---|---|
Changes in plasma concentrations of glucose and adiponectin over time as compared to baseline
Tijdsspanne: During two study sessions lasting 4 hours each and performed at least two weeks apart. Blood samples will be taken twice at baseline and then hourly afterwards (between time-points 0 minutes and 240 minutes)
|
Blood samples will be withdrawn from an intravenous cannula placed circa 10 minutes before the start of the study in the left antecubital vein.
Glucose will be routinely measured in a certified laboratory (www.kimcl.at).
Samples for the measurement of adiponectin will be immediately cooled on ice, centrifuged at 3000 rpm for 10 minutes and then stored at -20°C.
All adiponectin assays will be performed using commercial kits at the very end of the study with samples belonging to (both study days) one subject being measured within one kit.
|
During two study sessions lasting 4 hours each and performed at least two weeks apart. Blood samples will be taken twice at baseline and then hourly afterwards (between time-points 0 minutes and 240 minutes)
|
Changes in plasma concentrations of cortisol, adrenaline and noradrenaline over time as compared to baseline
Tijdsspanne: Timepoints -5, 0, 60, 120, 180 and 240 minutes.
|
Blood samples will be withdrawn from an intravenous cannula placed circa 10 minutes before the start of the study in the left antecubital vein.
Samples will be immediately cooled on ice, centrifuged at 3000 rpm for 10 minutes and then stored at -20°C for the later measurement of cortisol, adrenaline and noradrenaline.
These assays will be performed using commercial kits used for routine purposes at a certified laboratory (www.kimcl.at)
at the very end of the study with samples belonging to (both study days) one subject being measured within one kit.
|
Timepoints -5, 0, 60, 120, 180 and 240 minutes.
|
Changes in plasma concentrations of B-type natriuretic peptide (BNP) and atrial natriuretic peptide (ANP) over time as compared to baseline
Tijdsspanne: Timepoints -5, 0, 60, 120, 180 and 240 minutes.
|
Blood samples will be withdrawn from an intravenous cannula placed circa 10 minutes before the start of the study in the left antecubital vein in vacutainers containing heparin.
Samples will be immediately cooled on ice, centrifuged at 3000 rpm for 10 minutes and then stored at -20°C for the later measurement of BNP and ANP.
These assays will be performed using commercial kits used for routine purposes at a certified laboratory at the very end of the study with samples belonging to (both study days) one subject being measured within one kit.
|
Timepoints -5, 0, 60, 120, 180 and 240 minutes.
|
Changes in plasma concentrations of endothelial derived factors (endothelin, adrenomedullin and growth differentiation factor 15) over time as compared to baseline
Tijdsspanne: Timepoints -5, 0, 60, 120, 180 and 240 minutes.
|
Blood samples will be withdrawn from an intravenous cannula placed circa 10 minutes before the start of the study in the left antecubital vein.
Samples will be immediately cooled on ice, centrifuged at 3000 rpm for 10 minutes and then stored at -20°C.
All assays for adrenomedullin, endothelin and growth differentiation factor 15 will be performed using commercial kits used for routine purposes at a certified laboratory at the very end of the study with samples belonging to (both study days) one subject being measured within one kit.
|
Timepoints -5, 0, 60, 120, 180 and 240 minutes.
|
Medewerkers en onderzoekers
Sponsor
Onderzoekers
- Hoofdonderzoeker: Anton Luger, MD, Medical University of Vienna
Publicaties en nuttige links
Studie record data
Bestudeer belangrijke data
Studie start
Primaire voltooiing (Werkelijk)
Studie voltooiing (Werkelijk)
Studieregistratiedata
Eerst ingediend
Eerst ingediend dat voldeed aan de QC-criteria
Eerst geplaatst (Schatting)
Updates van studierecords
Laatste update geplaatst (Werkelijk)
Laatste update ingediend die voldeed aan QC-criteria
Laatst geverifieerd
Meer informatie
Termen gerelateerd aan deze studie
Trefwoorden
Andere studie-ID-nummers
- 060/2009
Deze informatie is zonder wijzigingen rechtstreeks van de website clinicaltrials.gov gehaald. Als u verzoeken heeft om uw onderzoeksgegevens te wijzigen, te verwijderen of bij te werken, neem dan contact op met register@clinicaltrials.gov. Zodra er een wijziging wordt doorgevoerd op clinicaltrials.gov, wordt deze ook automatisch bijgewerkt op onze website .
Klinische onderzoeken op Gezond
-
University of LeicesterNational Institute for Health Research, United KingdomVoltooidPatiënten met hartfalen en behouden ejectiefractie - HFpEF | Patiënten met hartfalen met verminderde ejectiefractie - HFrEF | Healthy Controls Group - Leeftijd en geslacht afgestemd
-
University Hospital, GrenobleUniversity Hospital, Clermont-Ferrand; Grenoble Institut des NeurosciencesBeëindigdZiekte van Parkinson | Healthy Controls Group - Leeftijd en geslacht afgestemdFrankrijk
Klinische onderzoeken op 0.9% NaCl
-
The Hospital for Sick ChildrenBeëindigd
-
Tianjin Medical University General HospitalWerving
-
Radboud University Medical CenterExponential Biotherapies Inc.OnbekendSystemisch ontstekingsreactiesyndroom | Coronaire bypass-transplantatieNederland
-
Carmel Medical CenterOnbekend
-
DLR German Aerospace CenterCharite University, Berlin, Germany; University of Erlangen-NürnbergVoltooidLaaggradige metabole acidoseDuitsland
-
Ahmad Jabir RahyussalimOnbekendMesenchymale stamcel | Spinale tuberculoseIndonesië
-
Aydin Adnan Menderes UniversityVoltooidPostoperatieve misselijkheid en brakenKalkoen
-
Phramongkutklao College of Medicine and HospitalOnbekend
-
Hamilton Health Sciences CorporationVoltooid
-
Korea University Anam HospitalVoltooidDiabetic Stable Angina | Diabetic Unstable AnginaKorea, republiek van